Compare USAU & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | USAU | DTIL |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 123.0M |
| IPO Year | N/A | 2019 |
| Metric | USAU | DTIL |
|---|---|---|
| Price | $16.64 | $4.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $19.00 | ★ $47.00 |
| AVG Volume (30 Days) | 193.9K | ★ 256.9K |
| Earning Date | 12-15-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $698,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.86 | $3.61 |
| 52 Week High | $19.20 | $8.82 |
| Indicator | USAU | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 54.37 | 37.00 |
| Support Level | $16.45 | $4.70 |
| Resistance Level | $17.45 | $5.20 |
| Average True Range (ATR) | 0.75 | 0.38 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 74.61 | 7.02 |
U.S. Gold Corp is an exploration and development company that owns certain mining leases and other mineral rights comprising the CK Gold Project in Wyoming, the Keystone Project in Nevada, and the Challis Gold Project in Idaho.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.